Disclosure Information The Disclosure Policy of Projects In Knowledge requires that faculty participating in a CME activity disclose to the audience any significant relationship they may have with a pharmaceutical or medical equipment company, product, or service that may be mentioned as part of their presentation, as well as any relationship with the commercial supporter of this activity. This independent CME activity is supported by an unrestricted educational grant from Schering Hepatitis Innovations. This activity may include a discussion of therapies that are unapproved for use or investigational, ongoing research, or preliminary data. The opinions expressed during this activity are those of the faculty and do not necessarily reflect those of the sponsor or the commercial supporter. Nezam H. Afdhal, MD, has received grant/research support from Diacrin Inc, Roche Pharmaceuticals, and Schering Corporation; has been a member of the speakers bureaus for Amgen Inc, Astra Merck Inc, Roche Pharmaceuticals, and Schering Corporation; and has been a consultant for Diacrin Inc. Douglas T. Dieterich, MD, has received grant/research support from Glaxo Wellcome, Inc, Roche Pharmaceuticals, and Schering Corporation; has been a consultant for Schering Corporation; and has been on the speakers bureaus for Glaxo Wellcome, Inc, Roche Pharmaceuticals, and Schering Corporation. Ira M. Jacobson, MD, has received grant/research support from Gilead Sciences, Glaxo Wellcome Inc, and Schering Corporation; and has been a member of the speakers bureaus for Glaxo Wellcome Inc, Roche Pharmaceuticals, and Schering Corporation. Karen L. Lindsay, MD, has received grant/research support from Glaxo Wellcome Inc, Hoffmann-La Roche, and Schering-Plough Corporation; and has been a consultant for Amgen Inc. Bruce A. Luxon, MD, PhD, has indicated no significant relationship. John G. McHutchison, MD, has received grant/research support from Amgen Inc, Bristol-Myers Squibb Company, and Schering Laboratories; and has been a member of the speakers bureaus for Amgen Inc; Chiron Corporation, and Schering Laboratories. Willis C. Maddrey, MD, has been a consultant for Amgen Inc, Glaxo Wellcome Inc, Eli Lilly and Company, Ribozyme Pharmaceuticals, Inc, and Schering Laboratories. Eugene R. Schiff, MD, has received grant/research support from Glaxo Wellcome Inc, Schering Laboratories, and SmithKline Beecham Pharmaceuticals; has been a consultant for Amgen Inc, Gilead Sciences, Glaxo Wellcome Inc, Medeva Pharmaceuticals, Inc, National Genetics Institute, Ortho, Roche Diagnostics, Schering Laboratories, and SciClone; and has been a member of the speakers bureaus for Amgen Inc, Astra Merck Inc, Glaxo Wellcome Inc, and Schering Laboratories. Mark S. Sulkowski, MD, has received grant/research support from Hoffmann La Roche and Schering Corporation; has been a consultant for Schering Corporation; and has been a member of the speakers bureaus for Ortho Biotech, Roche Pharmaceuticals, and Schering Corporation. World Wide Web pages are copyrighted and may not be reproduced in any form without the express written consent of Projects In Knowledge, Inc. Copyright © 2004, Projects In Knowledge, Inc. All rights reserved. For questions or comments regarding this web site please contact: Webmaster